JOHNSON & JOHNSON (JNJ:NYSE)
$263.81 -3.8 (-1.42%)
Analysed JOHNSON & JOHNSON (JNJ:NYSE) News Sources
Update: Market Chatter: Johnson & Johnson Orthopedics, Smith & Nephew Merger Collapsed Over Leadership Dispute
23-10-2026
yahoo.com
J&J Stock Reclaims 50-Day SMA: Is it Time to Buy, Sell or Hold?
23-10-2026
yahoo.com
Johnson & Johnson (JNJ) Stock Gets Fair Value Bump On Mixed Analyst Target Changes
23-10-2026
yahoo.com
Correction: Update: Market Chatter: Johnson & Johnson Orthopedics, Smith & Nephew Merger Collapsed Over Leadership Dispute
23-10-2026
yahoo.com
Smith And Nephew Merger Talks With Johnson & Johnson Collapse Over Leadership Dispute
23-10-2026
tikr.com
Sector Update: Healthcare Stocks Decline Friday Afternoon
23-10-2026
yahoo.com
Sector Update: Healthcare Stocks Fall Late Afternoon
23-10-2026
yahoo.com
J&J’s Smith & Nephew Deal Collapsed Over One Executive. Here’s What It Means for the DePuy Spin
24-10-2026
tikr.com
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
24-10-2026
yahoo.com
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
24-10-2026
fool.com
What is the current price of JOHNSON & JOHNSON (JNJ:NYSE)?
The current price of JOHNSON & JOHNSON (JNJ:NYSE) is $263.81.
JOHNSON & JOHNSON (JNJ:NYSE) absolute price change since previous trading day?
The absolute price change of JOHNSON & JOHNSON (JNJ:NYSE) since the previous trading day is $-3.8.
JOHNSON & JOHNSON (JNJ:NYSE) percentage price change since previous trading day?
The percentage price change of JOHNSON & JOHNSON (JNJ:NYSE) since the previous trading day is -1.42%.
What is the most recent average sentiment score for JOHNSON & JOHNSON (JNJ:NYSE)?
The most recent average sentiment score for JOHNSON & JOHNSON (JNJ:NYSE) is 28 out of 100.
What is the most recent average sentiment for JOHNSON & JOHNSON (JNJ:NYSE)?
The most recent sentiment for JOHNSON & JOHNSON (JNJ:NYSE) is .
SEC-8K** Filing Available For JOHNSON & JOHNSON (JNJ:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.